The Latest Breaking News from GILD

Despite an inflow of positive macro data, the Fed’s hawkish stance is expected to keep the markets under pressure for the near term. With price fluctuations being the new norm, dividend-paying stocks with solid fundamentals, BHP Group (BHP) and Gilead Sciences (GILD), could help jump-start a solid stream of passive…

While the better-than-expected GDP growth in the last quarter and declining inflationary pressures are raising optimism, macro uncertainties remain. With interest rate hikes expected to continue, recession possibilities cannot be ruled out. Therefore, fundamentally sound dividend-paying stocks, AbbVie (ABBV), Gilead Sciences (GILD), and Sisecam Resources (SIRE), could be worth investing…

Amid rising demand and government investments, the biotech industry is poised to witness significant growth in the foreseeable future. Given this backdrop, quality biotech stock Gilead Sciences (GILD) might be a wise addition to your portfolio this January. However, Stoke Therapeutics (STOK) could be best avoided, given its bleak fundamentals.…

With the Federal Reserve committed to bringing inflation down, a pause in interest rate hikes is not expected this year. This is expected to lead to an economic slowdown and keep the stock market volatile. Amid this backdrop, investors could add a high-yield stock, Gilead Sciences (GILD), to stabilize their…

Amid economic turmoil and recessionary fears, market volatility is anticipated to continue. However, this could be an opportune time for investors to scoop up quality top-rated stocks Gilead Sciences (GILD), Biogen (BIIB), and AudioCodes (AUDC) for the long haul. Read on….

With data starting to reveal signs of a slowdown in an economy burdened with inflation and reactive interest rate hikes, loading up on fundamentally strong stocks Gilead Sciences (GILD), Kronos Worldwide (KRO), and Bluegreen Vacations Holding (BVH) at discounted valuations could set investors up for outsized returns. Continue reading….

Thanks to easing inflation and indications of lower interest rate hikes by the Federal Reserve, the Nasdaq composite could rebound after its freefall last year. Given this backdrop, fundamentally sound Nasdaq stocks Cisco Systems (CSCO) and Gilead Sciences (GILD) could be ideal buy-and-hold options in 2023. Keep reading….

The biotech industry is expected to witness solid growth driven by growing government initiatives and increasing demand across several sectors. While we think fundamentally sound biotech stocks Gilead Sciences (GILD) and United Therapeutics (UTHR) could be solid buys this year, Bionano Genomics (BNGO) could be best avoided considering its fundamental…

While inflation pressures seem to be cooling, the Fed is expected to continue with its rate hikes, raising the chances of a recession this year. Hence, high-dividend stocks AbbVie (ABBV), Gilead Sciences (GILD), and Marine Products (MPX) might be solid buys for steady income amid current uncertainties. Keep reading.

The biotech industry flourished amid the pandemic, and lucrative federal investments are expected to drive further growth in the sector. Moreover, amid evolving variants of Coronavirus, the biotech industry is expected to remain in the limelight. Given the sound prospects of the industry, quality biotech stocks Gilead Sciences (GILD) and…

Although inflation has been showing signs of easing, it continues to hover way above the Fed’s 2% target. Since the Fed is expected to continue raising interest rates until its target is reached, the stock market is expected to remain volatile. Amid this backdrop, investors could consider investing in quality…